CC BY
42
THE POSSIBLE ROLE OF TOXOPLASMOSIS IN THE DEVELOPMENT OF ANTIPHOSPHOLIPID ANTIBODIES IN PREGNANCY-RELATED COMPLICATIONS
Bayati Ali Hattem Hussein
Lecturer, Suleimani Technical College Iraq, Suleimani City Mailing Adress: Iraq/Kurdistan Region/Suleimani City/ Suleimani Post Office/Post Office Box: 452 e-mail: dralihattem@yahoo.com
Zainab Abdulhussain Hamed
Lecturer, College of Medicine, University of Baghdad Iraq, Baghdad
The study studied the participation of toxoplasma gondii in the formation of antiphospholipid antibodies in pregnant women. The results showed that previous infection with toxoplasma gondii might lead to development antiphospholipid antibodies, which in turn might predispose to infertility, and abortion.
Key words: antiphospholipid antibodies, toxoplasmosis, pregnant women, abortion.
Introduction. Toxoplasmosis is a parasitic disease caused by the protozoan Toxoplasma gondii [1]. Congenital toxoplasmosis is a known fetal complication of infection during prenatal life from infected mother. Congenital infection leads to abortion, stillbirth, chorioretinitis, intracerebral calcifications, psychomotor disturbances, and hyd-rocyphaly or microcephaly. Prenatal toxoplasmosis is a major cause of blindness and other congenital defects [2]. Antiphospholipid syndrome or antiphospholipid antibody syndrome is a known disorder of coagulation [3], which causes blood clots (thrombosis) in both arteries and veins, as well as pregnancy-related complications such as miscarriage or stillbirth, preterm delivery, or severe preeclampsia. The syndrome occurs due to the autoimmune production of antibodies against phospholipid (aPL), a cell membrane substance. Antiphospholipid syndrome is an autoimmune disease, though the exact cause of the formation of antiphospholipid antibodies is not known [4; 5]. Toxoplasma gondii might play a role in the formation of these autoantibodies with their consequences on pregnancy [6].
Aim of study. This paper aims to study the possibility of participation of Toxo-plasma gondii in the formation of antiphospholipid antibodies in pregnant women.
Patients and Methods. The patient group was pregnant women were having antibody markers of recent or previous Toxoplasma gondii infection. The number of patient group was 118. The control group included healthy pregnant women with negative serological feature of Toxoplasma gondii infection. The control group was number and age matched with patient group. A signed consent was taken from each participant in the study. The study was done in Kamal Al-Samaraee Hospital in Baghdad through a period of 11 months (8—2009 until 7—2010). A questionnaire was designated to include demographical data and some other information related to pregnancy. For screening of blood, five-milliliter blood sample was collected aseptically into a sterile test tube from each woman in the study and tested for IgM anti-toxoplasma gondii antibodies and
Bayati Ali Hattem Hussein, Zainab Abdulhussain Hamed. The possible role of toxoplasmosis.
IgG anti-toxoplasma gondii antibodies, those who showed serological feature of Toxoplasma gondii infection (recent or previous) were included in patient group and further investigations for IgM anti-phospholipid antibodies, and IgG anti-phospholipid antibodies. The serological profile was determined by using Enzyme-Linked Immunosorbent Assay (ELISA). The assay has 99% sensitivity and 99% specificity. Samples were tested in duplicate and those who are positive for any of the above antibodies were re-tested. Results above the cutoff values were considered positive [7].
Statistical analysis. The mean age group, age intervals, time since marriage, number of abortions, and some other features were recorded. We set up a hypothesis that to be tested using Chi-Square test at 95% of confidence level and degree of freedom equal to one.
Results. The entire patients group had IgG anti-toxoplasma antibodies, while the IgM anti-toxoplasma antibodies were found in only six patients. The mean age of women was 32 (±2,4) and the age group 30—34 was the most frequent. The mean of duration since marriage is 6 years (±1,7). The results revealed that 17 (15,1%) women in patients group were positive for IgM antiphospholipid antibodies, while only one (0,8%) of control group was positive and the results were significant (P < 0,05). This is shown in table 1.
Table 1
Seroprevalence of IgM antiphospholipid antibodies in study groups
Serological markers Patients group Control group
Positive IgM antiphospholipid antibodies 17 1
Negative IgM antiphospholipid antibodies 101 117
X2 = 15,39; P < 0,05.
The IgG antiphospholipid antibodies were positive in 32 (27,12%) of patients group and only two (1,7%) of the control group, the results were significant (P < 0,05). This is demonstrated in table 2.
Table 2
Seroprevalence of IgG antiphospholipid antibodies in study groups
Serological markers Patients group Control group
Positive IgG antiphospholipid antibodies 32 2
Negative IgG antiphospholipid antibodies 86 116
X2 = 32,89; P < 0,05.
The pregnancy condition was followed in both groups and the number of abortions or stillbirths in study group was 30 (21 for those with IgM antiphospholipid antibodies and nine for those having IgG antiphospholipid antibodies), while only 8 of control group got abortions or stillbirths and the results were significant (P < 0,05), this is described in tables 3 and 4.
Table 3
The pregnancy outcome for patients group and control group
Pregnancy outcome Patients group Control group
Abortion or stillbirth 30 8
Full term labour 88 110
X2 = 15,18; P < 0,05.
Вестннк Py^H, cepua Медицина, 2012, № 3
Table 4
The pregnancy outcome for patients' group and control group
Infertility Patients group Control group
Primary infertility 12 5
Secondary infertility 22 1
No infertility 84 112
X2 = 23,6; P < 0,05.
The results revealed no correlation between the concentration of IgG antiphos-pholipid antibodies and the time of abortion or stillbirth, as the correlation coefficient (r) was close to zero.
The results showed that 34 of patients group (30,3%) have history of infertility, most of them having secondary infertility and showing IgG antiphospholipid antibodies, while only 6 (5%) of control group have history of infertility and most of them are primary infertility, and the results were significant (P < 0,05). This is demonstrated in table 4.
Discussion. Many studies showed that toxoplasma gondii infection and antiphospholipid antibodies are among many causes of pregnancy loss [8], but the possible participation of both in single pregnancy loss has not been studied before. APA represent a family of antibodies of different specificities, most of which are directed toward different anionic phospholipids, which include cardiolipin and phosphotidylcholine [9].
In this study, the highly significant differences regarding the presence of antiphos-pholipid antibodies of both types IgM and IgG in patients with toxoplasmosis when compared to those in control group illustrate the presence of a relation between toxo-plasma gondii infection and the possibility of developing antiphospholipid antibodies by mechanisms need to be explore. One possibility is the presence of autoimmune phenomenon that responsible for developing these autoantibodies due to antigen similarity between some toxoplasma gondii epitopes and human cell membrane antigens, which might lead to cross reactivity. Thus, antiphosphlipid antibodies in these patients might be post-toxoplasmal infection antibodies. Many studies suggest the pathological role of antiphosphlipid antibodies in pregnancy loss [10]. Antiphospholipid syndrome is well established as a cause of later miscarriages as it is associated with slow progressive thrombosis and infarction of the placenta, which could lead to pregnancy loss [11], though some physicians are still unsure about the role of antiphospholipid antibodies in early miscarriage [12].
There is no correlation between IgG concentration and the time of abortion, which might indicate the presence of many factors participating in pathogenesis of pregnancy loss. The presence of abortions, stillbirths, or infertility in those patients having anti-phospholipid antibodies without apparent or recent toxoplasma infection might reflect the participation of these autoantibodies in the pathogenesis of these complications during pregnancy.
Conclusion. The previous infection with toxoplasma gondii might lead to development of antiphospholipid antibodies, which in turn are responsible for infertility, abortion, and stillbirth. Thus, pregnant women show negative recent toxoplasma infections and have such complications should be screened for antiphospholipid antibodies.
BayatiAliHattem Hussein, Zainab Abdulhussain Hamed. The possible role of toxoplasmosis..
REFERENCES
[1] Weiss L.M., Dubey J.P. Toxoplasmosis: A history of clinical observations // Int J Parasitol. 1; 39(8):895—901. (2009).
[2] Berger F, Goulet V, Le Strat Y, et al. Toxoplasmosis among pregnant women in France: Risk factors and change of prevalence between 1995 and 2003 // Rev Epidemiol Sante Publique; 57(4):241—8. (2009).
[13] Caron P. Misita, PharmD; Stephan Moll, et al. Antiphospholipid Antibodies // Circulation; 2005; 112:39—44. (2005).
[4] Wilson WA, Gharavi AE, Koike T, Lockshin MD, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop // Arthritis Rheum.; 42: 1309—1311. (1999).
[5] Wang X, Chen C, Wang L, et al. Conception, early pregnancy loss, and time to clinical pregnancy: a population-based prospective study // Fertil Steril; 79(3): 577—84. (2003).
[6] Derksen RH, Khamashta MA, Branch DW. Management of the obstetric antiphospholipid syndrome // Arthritis Rheum; 50: 1028—39. (2004).
[7] Strhârsky J, Mad'arovâ L, Klement C. Laboratory diagnosis of toxoplasmosis // Epidemiol Mik-robiol Imunol.; 58(2):51—62. (2009).
[8] Flint S, Gibb DM. Recurrent second trimester miscarriage // Curr Opin Obstet Gynecol; 8: 449—53. (1996).
[9] Kultech WH, Rote NS, Silver R. Antiphospholipid antibodies and Reproduction: the anti-phos-pholipid antibody syndrome // Am. J. Reprod. Immunology; 42: 133—152. (1999).
[10] P L Meroni, N di Simone, C Testoni, et al. Antiphospholipid antibodies as cause of pregnancy loss // Lupus, Vol. 13, No. 9, 649—652. (2004).
[11] Lockshin MD. Anitphospholipid antibody // J Am Med Assoc; 277:1549—1551. (1997).
[12] Rai, R.S. «Antiphospholipid syndrome and recurrent miscarriage" // Journal of Postgraduate Medicine; 48 (1): 3—4. ( 2002).
ВОЗМОЖНАЯ РОЛЬ ТОКСОПЛАЗМОЗА В РАЗВИТИИ АНТИФОСФОЛИПИДНЫХ АНТИТЕЛ В СВЯЗАННЫХ С БЕРЕМЕННОСТЬЮ ОСЛОЖНЕНИЙ
Баяти Али Хатем Хусейна
преподаватель Сулеймание технический колледж Ирак, Сулеймание города Почтовый адрес: Иракские /Курдистана / Сулеймание Город / Suleimani Почта / почтовый ящик: 452 электронная почта: dralihattem@yahoo. com
Зайнаб Абдул Хуссейн Хамед
преподаватель, Медицинский колледж Университет Багдада Ирак, Багдад
Изучали участие токсоплазмы гондий в образовании антифосфолипидных антител у беременных женщин. Результаты показали, что предыдущие инфекции токсоплазмы гондий могут привести к развитию антифосфолипидных антител, что, в свою очередь, может предрасполагать к бесплодию и аборту.
Ключевые слова: антифосфолипидные антитела, токсоплазмоз беременных, аборт.
